CARMAT : Des nouvelles du patient Romain, il y a 3 j sur Link

yfallait

23 janv. 2024 •17:04

Francesco MusumeciFrancesco Musumeci
• 3e et + • 3e et +
Senior Consultant in Cardiac Surgery, Coordinator of Minimally Invasive Cardiac Surgery Program, UPMC - ISMETT, Palermo, ItalySenior Consultant in Cardiac Surgery, Coordinator of Minimally Invasive Cardiac Surgery Program, UPMC - ISMETT, Palermo, Italy
3 j • 3 j •

Suivre

The new Aeson CARMAT Total Artificial Heart: a promising therapeutic option for a safe bridging to heart transplantation. The first implant in Italy of the new device, in July 2023 at San Camillo Hospital in Rome, was in a 46 yrs old male patient with biventricular failure and INTERMACS class II/III. Indication for Total Artificial Heart were large body size (120 kg weight - 190 cm height) which made the chance of urgent transplantation remote. Seven months after the implantation the patient is doing extremely well and is on waiting for transplantation. This innovative technology in the future may extend its use to “elective heart
replacement”.

https://www.linkedin.com/search/results/content/?heroEntityKe y=urn%3Ali%3Aorganization%3A481119&keywords=carmat&position=3&search Id=020f7434-e87c-451e-a274-c32815f61d81&sid=Hcp&update=urn%3Ali%3Afs_upd ateV2%3A(urn%3Ali%3Aactivity%3A7154161373080432640%2CBLENDED_SEARCH_FEED%2CEMPTY %2CDEFAULT%2Cfalse)